Physical properties of hemoglobin vesicles as red cell substitutes

被引:89
作者
Sakai, H [1 ]
Hamada, K [1 ]
Takeoka, S [1 ]
Nishide, H [1 ]
Tsuchida, E [1 ]
机构
[1] WASEDA UNIV,DEPT POLYMER CHEM,TOKYO 169,JAPAN
关键词
D O I
10.1021/bp950068w
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hemoglobin vesicles (HbV) as red cell substitutes were prepared from a purified carbonylhemoglobin (HbCO) solution and a lipid mixture composed of phospholipids, cholesterol, and cr-tocopherol. The diameter was controlled to 251 +/- 87 nm using an extrusion method; the vesicles penetrated through the membrane filters with regulated pore sizes. After the ligand exchanging reaction (HbCO --> HbO(2)), the oxygen affinity (P-50) Of HbV was 32 Torr, which was controlled with the coencapsulation of pyridoxal 5'-phosphate. The rate of metHb formation in HbV was nonenzymatically reduced with the coencapsulation of DL-homocysteine. The Hb concentration of the HbV suspension, which was dispersed in a phosphate buffered saline solution (pH 7.4), was controlled at 10 g/dL. At this concentration, the total lipid concentration was 6.2 g/dL and the viscosity, 2.6 cP (230 s(-1)), was lower than that of the blood (4.4 cP). The HbV suspension showed a typical non-Newtonian flow for a particle dispersion and agreed well with the Casson model. The viscosity at shear rates lower than 23 s(-1) showed a maximum with increasing the mixing ratio of human blood, plasma, or albumin, while no maximum was observed for the mixture with washed red blood cells. The aggregates of HbV are formed by interaction with plasma proteins, including albumin, while the aggregates reversibly dissociate at higher shear rate.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 42 条
[11]   SYNTHESIS AND EVALUATION OF A PROTOTYPAL ARTIFICIAL RED-CELL [J].
HUNT, CA ;
BURNETTE, RR ;
MACGREGOR, RD ;
STRUBBE, AE ;
LAU, DT ;
TAYLOR, N ;
KIWADA, H .
SCIENCE, 1985, 230 (4730) :1165-1168
[12]  
IZUMI Y, 1996, IN PRESS CRIT CARE M
[13]  
LABRAKE CC, 1992, J BIOL CHEM, V267, P16703
[14]   A HUMAN RECOMBINANT HEMOGLOBIN DESIGNED FOR USE AS A BLOOD SUBSTITUTE [J].
LOOKER, D ;
ABBOTTBROWN, D ;
COZART, P ;
DURFEE, S ;
HOFFMAN, S ;
MATHEWS, AJ ;
MILLERROEHRICH, J ;
SHOEMAKER, S ;
TRIMBLE, S ;
FERMI, G ;
KOMIYAMA, NH ;
NAGAI, K ;
STETLER, GL .
NATURE, 1992, 356 (6366) :258-260
[15]   PROTEIN-LIPOSOME CONJUGATES WITH DEFINED SIZE DISTRIBUTIONS [J].
LOUGHREY, HC ;
WONG, KF ;
CHOI, LS ;
CULLIS, PR ;
BALLY, MB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1028 (01) :73-81
[16]   A KINETIC-STUDY ON FUNCTIONAL IMPAIRMENT OF NITRIC OXIDE-EXPOSED RAT ERYTHROCYTES [J].
MAEDA, N ;
IMAIZUMI, K ;
KON, K ;
SHIGA, T .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1987, 73 :171-177
[17]  
MAKINO C, 1991, NIHONKGAKUKAISHI, P1102
[18]  
OGATA Y, 1994, ARTIF BLOOD, V2, P62
[19]  
OHGUSHI T, 1994, ARTIF BLOOD, V2, P97
[20]  
OKA S, 1984, BIORHEOLOGY